NASDAQ:GRTX

Galera Therapeutics Stock Forecast

etoro logo Buy GRTX
*Your capital is at risk
$0.0871
-0.0047 (-5.07%)
At Close: Jun 15, 2026
AI Analysis AI Analysis of GRTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add GRTX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Galera Therapeutics, Inc. stock price took a fall of -5.07% on Monday
(Updated on Jun 15, 2026)

Sell candidate since Jun 12, 2026 Loss -5.07%

The Galera Therapeutics, Inc. stock price fell by -5.07% on the last day (Monday, 15th Jun 2026) from $0.0918 to $0.0871. During the last trading day the stock fluctuated 7.87% from a day low at $0.0851 to a day high of $0.0918. The price has fallen in 6 of the last 10 days and is down by -12.9% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -827 shares and in total, 0 shares were bought and sold for approximately $0 .

The stock has broken the very wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $0.0871. A reaction back to this level may hold a second chance to get out before further falls.

GRTX Signals & Forecast

There are few to no technical positive signals at the moment. The Galera Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0912 and $0.0979. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, June 12, 2026, and so far it has fallen -5.07%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Galera Therapeutics, Inc. stock

Galera Therapeutics, Inc. finds support from accumulated volume at $0.0862 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.0067 between high and low, or 7.87%. For the last week the stock has had daily average volatility of 6.80%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GRTX) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect Galera Therapeutics, Inc. to open at $0.0880, and during the day (based on 14 day Average True Range), to move between $0.0840 and $0.0902, which gives a possible trading interval of +/-$0.0063 (+/-7.47%) up or down from last closing price. If Galera Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0862 (1.03%) than the resistance at $0.0900 (3.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Galera Therapeutics, Inc. stock A Buy?

The Galera Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Galera Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.638 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 16, 2026 - $0.0880 ( 1.03%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

GRTX Performance

Trading levels for GRTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0947 8.73%
R2 0.0921 5.79%
R1 0.0906 3.97%
Price 0.0871
S1 0.0854 -1.91%
S2 0.0839 -3.72%
S3 0.0813 -6.66%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.102 16.53%
R2 0.100 14.81%
R1 0.0900 3.33%
Price 0.0871
S1 0.0862 -1.03%
S2 0.0850 -2.41%
S3 0.0789 -9.41%

FAQ

What is the symbol for Galera Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Galera Therapeutics, Inc. is GRTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Galera Therapeutics, Inc. Stock?
The Galera Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Galera Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Galera Therapeutics, Inc. Stock?
Galera Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Galera Therapeutics, Inc. Stock.

What's the current price of Galera Therapeutics, Inc. Stock?
As of the end of day on the Jun 15, 2026, the price of an Galera Therapeutics, Inc. (GRTX) share was $0.0871.

What is the 52-week high and low for Galera Therapeutics, Inc. Stock?
The 52-week high for Galera Therapeutics, Inc. Stock is $0.150 and the 52-week low is $0.0151.

What is the market capitalization of Galera Therapeutics, Inc. Stock?
As of the Jun 15, 2026, the market capitalization of Galera Therapeutics, Inc. is 6.61M.

When is the next earnings date for Galera Therapeutics, Inc.?
The upcoming earnings date for Galera Therapeutics, Inc. is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT GALERA THERAPEUTICS, INC.
Galera Therapeutics
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.84
4.82% Jun 11
EAT
$140.46
11.23% Jun 05
TPR
$140.47
7.49% Jun 04
LITE
$905.00
5.77% Jun 01
W
WCLD
$27.34
12.84% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE